Se consideran exclusivamente proyectos desarrollados en el seno del grupo de investigación, no otros proyectos desarrollados en colaboración con otros grupos de trabajo o sociedades científicas.
Dual trajectories of polypharmacy and medication regimen complexity index in people living with HIV in Spain
Farm Hosp 2024.
TRAYECTORIAS fh+.pdf
Documento Adobe Acrobat
430.8 KB
Influence of the Type of Antiretroviral Treatment on the Time to Reach High Pharmacotherapy Complexity in People Living With HIV
ALTAC annals.pdf
Documento Adobe Acrobat
709.1 KB
Analysis of antiretroviral therapy interruption in people living with HIV during the 2010-2021 period
MORILLO ANCADITAR.pdf
Documento Adobe Acrobat
578.2 KB
Concordance between two models of stratification for patients living with HIV infection to providing pharmaceutical care
MORILLO CORRELACION ESTRATIFICACION.pdf
Documento Adobe Acrobat
2.5 MB
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project
Rev Esp Quimioter. 2023 Sep 19:robustillo19sep2023. doi: 10.37201/req/021.2023.
ROBUSTILLO MORILLO DISPIMDINAC.pdf
Documento Adobe Acrobat
173.7 KB
Drug burden index in people living with HIV over 50 years of age in areal clinical practice cohort
Enferm Infecc Microbiol Clin (Engl Ed). 2023
DBI LAO ROBUSTILLO MORILLO.pdf
Documento Adobe Acrobat
813.4 KB
Influencia de la polifarmacia en la presencia simultánea de altacomplejidad farmacoterapéutica, interacciones medicamentosasy no adherencia a la medicación en pacientes con infección por VIH.
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jun-Jul;41(6):342-347. doi: 10.1016/j.eimce.2022.09.007.
3-HIT CONTRERAS, PIZARRAYA, MORILLO.pdf
Documento Adobe Acrobat
356.0 KB
Potentially inappropriate medications according to Marc, STOPP and PRISCUS criteria in a cohort of elderly HIV+ patients. The COMMPI project
Rev Esp Quim. 2023
COMMPI.pdf
Documento Adobe Acrobat
152.7 KB
Prevalence of compliance with PIMDINAC criteria among elderly people living with HIV and in non-infected outpatients with other chronic diseases
Eur J Hosp Pharm. 2022 Dec 30:ejhpharm-2022-003454. doi: 10.1136/ejhpharm-2022-003454
CROSPIMDINAC CANTUDO GARCIA GABELLA MORI
Documento Adobe Acrobat
254.7 KB
Clinical Impact of the Capacity-Motivation- Opportunity Pharmacist-Led Intervention in People Living with HIV in Spain, 2019–2020
CMO MORILLO ROBUSTILLO.pdf
Documento Adobe Acrobat
470.3 KB
Intervención farmacéutica basada en la metodología CMO para la mejora de la adherencia primaria a la medicación concomitante en pacientes con infección por VIH: Proyecto PRICMO
PRICMO Farm Hosp 2021.pdf
Documento Adobe Acrobat
1.3 MB
Influence of CMO pharmaceutical care model-based intervention on readmission rate in high risk HIV patients: the INFARDAR study
Revista Española de Quimioterapia 2021. doi:10.37201/req/025.2021
INFARDAR.pdf
Documento Adobe Acrobat
376.3 KB
Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity
pharmaceutical care model: the IRAFE study
Eur J Hosp Pharm. 2021 Feb 24;ejhpharm-2020-002330.
High level of medication regimen complexity index correlate with worse quality of life in people living with HIV
Rev Esp Quimioter 2021; January 27. DOI: 10.37201/req/097.2020
QOLIC.pdf
Documento Adobe Acrobat
363.4 KB
Prevalence of PIMDINAC criteria and associated factors in elderly HIV patients
Enferm
Infecc Microbiol Clin. 2021 Jan 12:S0213-005X(20)30417-1. doi: 10.1016/j.eimc.2020.11.014.
Beliefs and attitudes about deprescription in older HIV-infected patients: ICARD project.
Rev Esp Quimioter 2020. oi:10.37201/req/084.2020 -
ICARD.pdf
Documento Adobe Acrobat
4.2 MB
Prevalence of prescription of the Top-10 drug classes to avoid in elderly people living with HIV in a real practice cohort
Rev Esp Quimioter 2020. 10.37201/req/087.2020
TOP-TEN.pdf
Documento Adobe Acrobat
92.9 KB
Influence of pharmacist intervention, based on CMO model, to improve activation in HIV patients
Rev Esp Quimioter 2019;32(1): 40-49
PAM articulo.pdf
Documento Adobe Acrobat
429.9 KB
Gastroenterol Hepatol. 2020 Apr 9. pii: S0210-5705(20)30071-6. doi:
10.1016/j.gastrohep.2020.02.011.
Hosp
Pharm. 2019 Dec;54(6):348-350.
Determination of a cutoff value for medication regimen complexity index to predict polypharmacy in HIV+ older patient.
Rev Esp
Quimioter. 2019t;32(5):458-464..
revespquimioter-32-458.pdf
Documento Adobe Acrobat
151.6 KB
Influence of pharmacist intervention, based on CMO model, to improve activation in HIV patients
Rev Esp Quimioter 2019;32(1): 40-49
PAM articulo.pdf
Documento Adobe Acrobat
429.9 KB
Concordancia entre la complejidad farmacoterapéutica calculada y la percibida por los pacientes VIH+ en tratamiento antirretroviral
Farm Hosp. 2019;43(1):31-5
pervichivda publicacion.pdf
Documento Adobe Acrobat
244.2 KB
Effect of a Structured Pharmaceutical Care Intervention Versus Usual Care on Cardiovascular Risk in HIV Patients on Antiretroviral Therapy: INFAMERICA Study
Ann Pharmacother. 2018, Vol. 52(11) 1098–1108
articulo publicado.pdf
Documento Adobe Acrobat
368.7 KB
Evaluación de la experiencia del paciente VIH+ con la atención farmacéutica basada en la metodología CMO
Farm Hosp.
IEXPAC.pdf
Documento Adobe Acrobat
1.9 MB
Identification of the Medication Regimen Complexity Index as an Associated Factor of Nonadherence to Antiretroviral Treatment in HIV+Patients
Ann Pharmacother. 2018: 1:1-6.
Compexity index factor associated adhern
Documento Adobe Acrobat
79.5 KB
Evolución del índice de complejidad de la terapia antirretroviral en paciente VIH en una cohorte de práctica clínica real
Rev Esp Quimioter 2017; Nov 7
manzano07nov2017.pdf
Documento Adobe Acrobat
143.3 KB
Influence of hospital admission in the pharmacotherapy complexity of HIV+ patients
Farm Hosp. 2017;41:518-26.
complejidad ingreso.pdf
Documento Adobe Acrobat
301.1 KB
Relationship between pharmacotherapy complexity and patient satisfaction with treatment for hepatitis C
Farm Hosp. 2017;41:470-78.
satisfaccion vhc.pdf
Documento Adobe Acrobat
303.3 KB
Eur J Hosp Pharm Published Online First: 23 February 2017. doi: 10.1136/ejhpharm-2016-001000
Development of a risk stratification model for pharmaceutical care in HIV patients
HIV RISK STRATIFICATION.pdf
Documento Adobe Acrobat
560.7 KB
Farm Hosp. 2017;41(3):346-356
Aten Farm. Eur J Clin Pharm. 2017; 19:(1): 16-23.
Análisis del cumplimiento de los indicadores de calidad de GESIDA en la cohorte de pacientes VIH+ PSITAR
Rev. OFIL 2016, 26;4:251-257
PSITAR.pdf
Documento Adobe Acrobat
92.4 KB
Development of a taxonomy for pharmaceutical interventions in HIV+ patients based on the CMO model
Farm Hosp. 2016; 40 (6): 544-568
CMO FH.pdf
Documento Adobe Acrobat
832.0 KB
Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy
Farm Hosp. 2016;40 (4):272-8
STR VS LDR.pdf
Documento Adobe Acrobat
383.8 KB
Farm Hosp. 2016; 40 (2): 90-101
INCOFAR.pdf
Documento Adobe Acrobat
394.7 KB
Efecto de los mensajes cortos de texto sobre la adherencia al tratamiento antirretroviral en pacientes VIH+
Rev. OFIL 2016, 26;1:35-40
Eur J Hosp Pharm 2016 doi:10.1136/ejhpharm-2015-000788
Influencia de las creencias hacia los medicamentos en la adherencia al tratamiento concomitante en pacientes VIH+
Farm Hosp. 2015;39(1):23-28
estudio creencias.pdf
Documento Adobe Acrobat
252.5 KB
Influence of Treatment Complexity on Adherence and Incidence of Blips in HIV/HCV Coinfected Patients
J Manag Care Pharm. 2015;21(2):153-57
articulo blips.pdf
Documento Adobe Acrobat
442.1 KB
Eur J Clin Pharm 2014;6:427-32.
Farm Hosp. 2014;38(4):291-299
ESTUDIO ARPAS.pdf
Documento Adobe Acrobat
122.7 KB
JMCP 2014, 20 (8): 844-50
Nuevos Farmacos en el abordaje terapeutico de la hepatitis C.
Farm Hosp. 2014;38(3):231-247
revision hepatitis C.pdf
Documento Adobe Acrobat
306.0 KB
Situación actual de la estructura, procesos y resultados
de la Atención Farmacéutica al paciente VIH en España.
Proyecto origen.Farm Hosp. 2014;38(2):89-99
origen.pdf
Documento Adobe Acrobat
132.0 KB
A better regulation is required in viral hepatitis
smartphone applications. Farm Hosp. 2014;38(2):112-117
apps hepatitis.pdf
Documento Adobe Acrobat
109.3 KB
Availability and medical professional involvement in mobile healthcare applications related to pathophysiology and pharmacotherapy of HIV/AIDS. Eur J Hosp Pharm 2013;20:6 356-361
articulo etravirina.pdf
Documento Adobe Acrobat
492.6 KB
PREVALENCIA Y FACTORES ASOCIADOS AL INSO
Documento Adobe Acrobat
553.8 KB
INDICADORES CALIDAD ASISTENCIAL VIH+.pdf
Documento Adobe Acrobat
121.5 KB
ic-rvs.pdf
Documento Adobe Acrobat
500.2 KB
Editorial AF VIH. Farm Hosp 2013
EDITORIAL VIH.pdf
Documento Adobe Acrobat
75.6 KB
Editorial Nueva era VHC. Farm Hosp 2012
Editorial FH 2012-6.pdf
Documento Adobe Acrobat
86.5 KB
PROPUESTA DE INDICADORES DE CALIDAD EN ATENCION FARMACEUTICA VIH
Documento publicado por la SECA. Diciembre-2012
INDICADORES DE CALIDAD VIH.pdf
Documento Adobe Acrobat
1.0 MB
ESTUDIO PREDICTOR.pdf
Documento Adobe Acrobat
545.5 KB
ANDHALUSIDA.pdf
Documento Adobe Acrobat
431.2 KB